Patents by Inventor Ronald Duman

Ronald Duman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination Therapy for Treating or Preventing Depression or Other Mood Diseases
    Publication number: 20240033254
    Abstract: The present invention provides compositions and methods for treating diseases or disorders using a therapeutically effective amount of a rapid-acting antidepressant (RAAD) and a therapeutically effective amount of a mTOR inhibitor and/or immunosuppressant. In certain embodiments, the RAAD and the mTOR inhibitor and/or immunosuppressant are part of a single pharmaceutical composition.
    Type: Application
    Filed: October 9, 2023
    Publication date: February 1, 2024
    Inventors: Chadi Abdallah, John Krystal, Ronald Duman, Gerard Sanacora
  • Combination therapy for treating or preventing depression or other mood diseases
    Patent number: 11793794
    Abstract: The present invention provides compositions and methods for treating diseases or disorders using a therapeutically effective amount of a rapid-acting antidepressant (RAAD) and a therapeutically effective amount of a mTOR inhibitor and/or immunosuppressant. In certain embodiments, the RAAD and the mTOR inhibitor and/or immunosuppressant are part of a single pharmaceutical composition.
    Type: Grant
    Filed: October 25, 2022
    Date of Patent: October 24, 2023
    Assignees: YALE UNIVERSITY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Chadi Abdallah, John Krystal, Ronald Duman, Gerard Sanacora
  • Combination Therapy for Treating or Preventing Depression or Other Mood Diseases
    Publication number: 20230070600
    Abstract: The present invention provides compositions and methods for treating diseases or disorders using a therapeutically effective amount of a rapid-acting antidepressant (RAAD) and a therapeutically effective amount of a mTOR inhibitor and/or immunosuppressant. In certain embodiments, the RAAD and the mTOR inhibitor and/or immunosuppressant are part of a single pharmaceutical composition.
    Type: Application
    Filed: October 25, 2022
    Publication date: March 9, 2023
    Inventors: Chadi Abdallah, John Krystal, Ronald Duman, Gerard Sanacora
  • Combination Therapy for Treating or Preventing Depression or Other Mood Diseases
    Publication number: 20210251969
    Abstract: The present invention provides compositions and methods for treating diseases or disorders using a therapeutically effective amount of a rapid-acting antidepressant (RAAD) and a therapeutically effective amount of a mTOR inhibitor and/or immunosuppressant. In certain embodiments, the RAAD and the mTOR inhibitor and/or immunosuppressant are part of a single pharmaceutical composition.
    Type: Application
    Filed: August 20, 2019
    Publication date: August 19, 2021
    Inventors: Chadi Abdallah, John Krystal, Ronald Duman, Gerard Sanacora
  • Systems and methods for diagnosing & treating psychological and behavioral conditions
    Publication number: 20050084880
    Abstract: The systems and methods described herein include microarray systems and methods for manufacturing and printing microarrays to provide gene chips capable of detecting signatures of psychiatric conditions, and as well as gene chips and arrays of sequences for such applications. The invention further provides methods of identifying gene signatures for psychiatric conditions, methods of treating such conditions, and methods of identifying therapeutics for the treatment of neurological and psychiatric conditions.
    Type: Application
    Filed: July 12, 2004
    Publication date: April 21, 2005
    Inventors: Ronald Duman, Samuel Sathyanesan
  • MC4-R as target for the identification of compounds used to treat drug addiction
    Publication number: 20030017966
    Abstract: The present invention relates to drug screening assays and therapeutic methods for the treatment of addictive behavior disorders, such as cocaine and morphine addiction utilizing the melanocortin 4-receptor (MC4-R) as the target for intervention. The invention also relates to compounds that antagonize the activity or expression of the MC4-R, and the use of such compounds in the treatment of addictive behavior disorders.
    Type: Application
    Filed: August 23, 2002
    Publication date: January 23, 2003
    Applicant: Yale University, a Connecticut corporation
    Inventor: Ronald Duman